Sanofi, AstraZeneca and Sobi’s Streamlining of Nirsevimab Contractual Arrangements

Pietro Martinoia
Tagged:

Latham & Watkins represented Sobi in the transaction.Sanofi has simplified its contractual arrangements relating to the development and commercialization of Beyfortus (nirsevimab) in the United States…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Pietro Martinoia

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here